Search Results - "Isola, J J"

Refine Results
  1. 1

    Differences in body temperature between black-and-white and red-and-white Holstein cows reared on a hot climate using infrared thermography by Isola, J.V.V., Menegazzi, G., Busanello, M., dos Santos, S.B., Agner, H.S.S., Sarubbi, J.

    Published in Journal of thermal biology (01-12-2020)
    “…Heat stress is one of the greatest issues of the dairy industry in regions with hot climate. Since coat color appears to be related to heat stress…”
    Get full text
    Journal Article
  2. 2

    Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab by Tanner, M., Hollmén, M., Junttila, T. T., Kapanen, A. I., Tommola, S., Soini, Y., Helin, H., Salo, J., Joensuu, H., Sihvo, E., Elenius, K., Isola, J.

    Published in Annals of oncology (01-02-2005)
    “…Background:HER-2/neu gene amplification has predictive value in breast cancer patients responding to trastuzumab. We wanted to investigate the frequency and…”
    Get full text
    Journal Article
  3. 3

    Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry by Veskimäe, K., Staff, S., Grönholm, A., Pesu, M., Laaksonen, M., Nykter, M., Isola, J., Mäenpää, J.

    Published in Tumor biology (01-09-2016)
    “…Targeting Poly (ADP-ribose) polymerase 1 (PARP-1) involved in base excision repair (BER) has been shown to be a clinically effective treatment strategy in…”
    Get full text
    Journal Article
  4. 4

    Frequent Amplification of Chromosomal Region 20q12-q13 in Ovarian Cancer by Tanner, M M, Grenman, S, Koul, A, Johannsson, O, Meltzer, P, Pejovic, T, Borg, A, Isola, J J

    Published in Clinical cancer research (01-05-2000)
    “…DNA amplification at chromosomal region 20q12-q13, which is common in breast cancer, has recently been described also in ovarian tumors. We studied the…”
    Get full text
    Journal Article
  5. 5

    Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland by Korhonen, K., Raitanen, J., Isola, J., Haapasalo, H., Salminen, T., Auvinen, A.

    Published in Cancer causes & control (01-12-2010)
    “…Background Previous studies on association of exogenous female sex hormones and risk for meningioma have yielded conflicting results. The aim of this study was…”
    Get full text
    Journal Article
  6. 6

    Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours by Laakso, M, Tanner, M, Isola, J

    Published in The Journal of pathology (01-09-2006)
    “…Chromogenic in situ hybridization (CISH), which uses an enzymatic reaction to detect the hybridized DNA probe, is a new alternative to fluorescence in situ…”
    Get full text
    Journal Article
  7. 7

    Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study by HOLLI, K, SAARISTO, R, ISOLA, J, JOENSUU, H, HAKAMA, M

    Published in British journal of cancer (2001)
    “…The aim of this trial was to study the value of adding post-operative radiotherapy to lumpectomy in a subgroup of breast cancer patients with favourable…”
    Get full text
    Journal Article
  8. 8

    A digital atlas of breast histopathology: an application of web based virtual microscopy by Lundin, M, Lundin, J, Helin, H, Isola, J

    Published in Journal of clinical pathology (01-12-2004)
    “…Aims: To develop an educationally useful atlas of breast histopathology, using advanced web based virtual microscopy technology. Methods: By using a robotic…”
    Get full text
    Journal Article
  9. 9

    Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization by VISAKORPI, T, KALLIONIEMI, A. H, SYVÄNEN, A.-C, HYYTINEN, E. R, KARHU, R, TAMMELA, T, ISOLA, J. J, KALLIONIEMI, O.-P

    Published in Cancer research (Chicago, Ill.) (15-01-1995)
    “…Genetic changes leading to the development of prostate cancer and factors that underlie the clinical progression of the disease are poorly characterized. Here,…”
    Get full text
    Journal Article
  10. 10

    Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy by Kuukasjärvi, T, Kononen, J, Helin, H, Holli, K, Isola, J

    Published in Journal of clinical oncology (01-09-1996)
    “…Up to 30% to 40% of metastases from hormone receptor-positive primary breast cancer do not respond to endocrine therapy. We studied how often hormone receptor…”
    Get more information
    Journal Article
  11. 11

    Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer by Isola, JJ, Kallioniemi, OP, Chu, LW, Fuqua, SA, Hilsenbeck, SG, Osborne, CK, Waldman, FM

    Published in The American journal of pathology (01-10-1995)
    “…Breast cancer progression is determined by a complex pattern of multiple genetic aberrations the association of which with patient prognosis is unknown. In…”
    Get full text
    Journal Article
  12. 12

    Very high quantitative tumor HER2 content and outcome in early breast cancer by Joensuu, H., Sperinde, J., Leinonen, M., Huang, W., Weidler, J., Bono, P., Kataja, V., Kokko, R., Turpeenniemi-Hujanen, T., Jyrkkiö, S., Isola, J., Kellokumpu-Lehtinen, P.-L., Paquet, A., Lie, Y., Bates, M.

    Published in Annals of oncology (01-09-2011)
    “…It is unknown how a very high tumor total HER2 (human epidermal growth factor receptor-2) content (H2T) influences outcome in early breast cancer treated with…”
    Get full text
    Journal Article
  13. 13

    Overall and worst gleason scores are equally good predictors of prostate cancer progression by Tolonen, Teemu T, Kujala, Paula M, Tammela, Teuvo L J, Tuominen, Vilppu J, Isola, Jorma J, Visakorpi, Tapio

    Published in BMC urology (06-10-2011)
    “…Gleason scoring has experienced several modifications during the past decade. So far, only one study has compared the prognostic abilities of worst (WGS) and…”
    Get full text
    Journal Article
  14. 14

    Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors by Isola, J J

    Published in The Journal of pathology (01-05-1993)
    “…Androgen actions and androgen receptors (ARs) have been described in human breast cancer cells both in vivo and in vitro. With the use of a new monoclonal…”
    Get more information
    Journal Article
  15. 15

    p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial by Di Leo, A, Tanner, M, Desmedt, C, Paesmans, M, Cardoso, F, Durbecq, V, Chan, S, Perren, T, Aapro, M, Sotiriou, C, Piccart, MJ, Larsimont, D, Isola, J

    Published in Annals of oncology (01-06-2007)
    “…Background: Preclinical data indicate that p-53 gene mutations predict resistance to doxorubicin (A) but not to docetaxel (Taxotere) (T). In the TAX 303 trial,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients by Juuti-Uusitalo, K, Mäki, M, Kainulainen, H, Isola, J, Kaukinen, K

    Published in Clinical and experimental immunology (01-11-2007)
    “…In coeliac disease gluten induces an immunological reaction in genetically susceptible patients, and influences on epithelial cell proliferation and…”
    Get full text
    Journal Article
  18. 18

    Low biologic aggressiveness in breast cancer in women using hormone replacement therapy by Holli, K, Isola, J, Cuzick, J

    Published in Journal of clinical oncology (01-09-1998)
    “…Hormone replacement therapy (HRT) has been associated with an increased risk for breast cancer. Cancers in women who use HRT are often less advanced, and lower…”
    Get more information
    Journal Article
  19. 19

    A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals by Konsti, J, Lundin, J, Jumppanen, M, Lundin, M, Viitanen, A, Isola, J

    Published in Journal of clinical pathology (01-03-2008)
    “…To develop and evaluate an automated method for quantification of HER2 fluorescence in situ hybridisation (FISH) signals. Using a popular, open source image…”
    Get more information
    Journal Article
  20. 20

    Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer by SIITONEN, S. M, KONONEN, J. T, HELIN, H. J, RANTALA, I. S, HOLLI, K. A, ISOLA, J. J

    Published in American journal of clinical pathology (01-04-1996)
    “…E-cadherin (E-cad) is a calcium-dependent, epithelial cell adhesion molecule whose reduced or lost expression has been associated with tumor dedifferentiation…”
    Get full text
    Conference Proceeding Journal Article